Countering the prevailing thought that more medical testing and treatment is always better can be achieved by creating a forum for open discussion of costs and value to prevent patient harm from overuse.
AMA J Ethics. 2015;17(11):1079-1081. doi:
10.1001/journalofethics.2015.17.11.mnar1-1511.
Rayner Kay Jin Tan, Jane Mingjie Lim, MSW, and Jeremiah Kah Wai Chan, MSc
Merits and drawbacks of U = U messaging are ethically and clinically complex, and drawbacks could harm patients in whom viral suppression is hard to achieve.
AMA J Ethics. 2021;23(5):E418-422. doi:
10.1001/amajethics.2021.418.
E. Berryhill McCarty, MA, MSHCPM and Lance Wahlert, PhD
Global transformation demanded by COVID-19 prompts consideration of how prior epidemics have shaped our cultural and sociological understandings of health care experiences.
AMA J Ethics. 2021;23(5):E423-427. doi:
10.1001/amajethics.2021.423.
Samuel G. Ruchman, Prabhjot Singh, MD, PhD, and Anna Stapleton
What can American health systems developers learn from abroad? Leading programs draw on global lessons to build sustainable and effective care in the US.
AMA J Ethics. 2016;18(7):736-742. doi:
10.1001/journalofethics.2016.18.7.msoc1-1607.
Aminu Yakubu, Nchangwi Syntia Munung, and Jantina De Vries, PhD
African cancer research is embedded in underresourced health care infrastructures, illuminating ethical questions about benefit sharing and governance.
AMA J Ethics. 2020;22(2):E156-163. doi:
10.1001/amajethics.2020.156.